Halozyme Therapeutics in (halo 1 08/15/28)
13F holders, Q3 2025 (September 30)8holders −1
3new positions
4sold out
$1.36avg. 13F price*
At the end of Q3 2025, 8 institutions reported holding Halozyme Therapeutics in (halo 1 08/15/28) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Absolute Investment Advisers, LLC ($19.7M), Ofi Invest Asset Management ($8.2M) and State of Wisconsin Investment Board ($4.2M).
- Company
- Halozyme Therapeutics in (halo 1 08/15/28)
- CUSIP
- 40637HAF6
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $4.2M |
| Exits | 4 | $1.6M |
All 13F filers, Q2 2025 → Q3 2025: 3,012,100 shares bought and 1,539,846 shares sold, net +1,472,254 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Absolute Investment Advisers, LLC | 2.47% | No change | 14,000,000 | $19.7M |
| Ofi Invest Asset Management | 0.17% | Reduce -8.1% | 6,800,000 | $8.2M |
| State of Wisconsin Investment Board | 0.01% | New | 3,000,000 | $4.2M |
| Sonora Investment Management Group, LLC | 0.22% | Reduce -1.6% | 2,230,000 | $3.2M |
| Bank of New York Mellon Corp | 0.00% | Reduce -41.2% | 500,000 | $703K |
| Loomis Sayles & Co. L P | 0.00% | No change | 3,570 | $262K |
| Fifth Third Bancorp | 0.00% | New | 10,000 | $14K |
| Boussard & Gavaudan Investment Management LLP | 0.00% | New | 2,100 | $3K |
"% of holder's portfolio" is HALOZYME THERAPEUTICS IN (HALO 1 08/15/28)'s weight in each manager's 13F, not the share of Halozyme Therapeutics in (halo 1 08/15/28) the manager owns.